|
US3536809A
(en)
|
1969-02-17 |
1970-10-27 |
Alza Corp |
Medication method
|
|
US3598123A
(en)
*
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US3845770A
(en)
*
|
1972-06-05 |
1974-11-05 |
Alza Corp |
Osmatic dispensing device for releasing beneficial agent
|
|
US3916899A
(en)
|
1973-04-25 |
1975-11-04 |
Alza Corp |
Osmotic dispensing device with maximum and minimum sizes for the passageway
|
|
US4008719A
(en)
|
1976-02-02 |
1977-02-22 |
Alza Corporation |
Osmotic system having laminar arrangement for programming delivery of active agent
|
|
US4409229A
(en)
|
1977-12-02 |
1983-10-11 |
Hoechst-Roussel Pharmaceuticals, Inc. |
Antidepressive and tranquilizing substituted 1,3-dihydrospiro[benzo(c)thiophene]s
|
|
IE58110B1
(en)
|
1984-10-30 |
1993-07-14 |
Elan Corp Plc |
Controlled release powder and process for its preparation
|
|
DE3440141A1
(de)
|
1984-11-02 |
1986-05-07 |
Heiner Dipl.-Chem. Dr. 8000 München Eckert |
Verwendung von kohlensaeure-bis-trichlormethylester als proreagens fuer phosgen
|
|
JPH0680054B2
(ja)
|
1985-06-19 |
1994-10-12 |
吉富製薬株式会社 |
ピペリジン誘導体
|
|
JPS6289679U
(https=)
|
1985-11-22 |
1987-06-08 |
|
|
|
US4797419A
(en)
*
|
1986-11-03 |
1989-01-10 |
Warner-Lambert Company |
Method of treating the symptoms of senile cognitive decline employing di- or trisubstituted urea cholinergic agents
|
|
US4866197A
(en)
|
1987-12-23 |
1989-09-12 |
American Home Products Corporation |
Production of N-((2-alkoxy-6-methoxy-5-(trifluoromethyl)-1-naphthalenyl)carbonyl)-N-methylglycine esters
|
|
US5073543A
(en)
|
1988-07-21 |
1991-12-17 |
G. D. Searle & Co. |
Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
|
|
DE3905364A1
(de)
*
|
1989-02-22 |
1990-08-23 |
Hoechst Ag |
Substituierte pyrimidin-derivate, verfahren zu ihrer herstellung und ihre verwendung als tool
|
|
IT1229203B
(it)
*
|
1989-03-22 |
1991-07-25 |
Bioresearch Spa |
Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
|
|
US5120548A
(en)
*
|
1989-11-07 |
1992-06-09 |
Merck & Co., Inc. |
Swelling modulated polymeric drug delivery device
|
|
US5733566A
(en)
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
|
PT97888B
(pt)
*
|
1990-06-07 |
1998-12-31 |
Zeneca Ltd |
Processo para a preparacao de compostos heterociclicos derivados de indol e de composicoes farmaceuticas que os contem
|
|
US5698155A
(en)
*
|
1991-05-31 |
1997-12-16 |
Gs Technologies, Inc. |
Method for the manufacture of pharmaceutical cellulose capsules
|
|
US5580578A
(en)
*
|
1992-01-27 |
1996-12-03 |
Euro-Celtique, S.A. |
Controlled release formulations coated with aqueous dispersions of acrylic polymers
|
|
JP3191429B2
(ja)
|
1992-09-02 |
2001-07-23 |
富士通テン株式会社 |
電子機器の挿排装置
|
|
US5728704A
(en)
*
|
1992-09-28 |
1998-03-17 |
Pfizer Inc. |
Substituted pyridmidines for control of diabetic complications
|
|
DE4234295A1
(de)
*
|
1992-10-12 |
1994-04-14 |
Thomae Gmbh Dr K |
Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
|
|
US5591767A
(en)
*
|
1993-01-25 |
1997-01-07 |
Pharmetrix Corporation |
Liquid reservoir transdermal patch for the administration of ketorolac
|
|
DE4302051A1
(de)
|
1993-01-26 |
1994-07-28 |
Thomae Gmbh Dr K |
5-gliedrige Heterocyclen, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
|
|
IT1270594B
(it)
*
|
1994-07-07 |
1997-05-07 |
Recordati Chem Pharm |
Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
|
|
DE19514313A1
(de)
*
|
1994-08-03 |
1996-02-08 |
Bayer Ag |
Benzoxazolyl- und Benzothiazolyloxazolidinone
|
|
DE69635048T2
(de)
|
1995-06-12 |
2006-02-16 |
G.D. Searle & Co. |
Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
|
|
RU2167865C2
(ru)
*
|
1995-09-07 |
2001-05-27 |
Ф. Хоффманн-Ля Рош Аг |
Производные пиперидина, способ их получения, фармацевтическая композиция на их основе и промежуточные вещества
|
|
EP0861075A1
(en)
*
|
1995-11-13 |
1998-09-02 |
Albany Medical College |
Analgesic compounds and uses thereof
|
|
FR2744448B1
(fr)
|
1996-02-02 |
1998-04-24 |
Pf Medicament |
Nouvelles piperidines derivees d'aryl piperazine, ainsi que leur procede de preparation, les compositions pharmaceutiques et leur utilisation comme medicaments
|
|
US5891889A
(en)
|
1996-04-03 |
1999-04-06 |
Merck & Co., Inc. |
Inhibitors of farnesyl-protein transferase
|
|
JP2001519766A
(ja)
|
1996-04-03 |
2001-10-23 |
メルク エンド カンパニー インコーポレーテッド |
ファルネシルタンパク質トランスフェラーゼの阻害剤
|
|
US5948786A
(en)
*
|
1996-04-12 |
1999-09-07 |
Sumitomo Pharmaceuticals Company, Limited |
Piperidinylpyrimidine derivatives
|
|
US5854245A
(en)
*
|
1996-06-28 |
1998-12-29 |
Merck & Co., Inc. |
Fibrinogen receptor antagonists
|
|
US5990107A
(en)
*
|
1996-06-28 |
1999-11-23 |
Merck & Co., Inc. |
Fibrinogen receptor antagonist prodrugs
|
|
US5798360A
(en)
*
|
1996-08-01 |
1998-08-25 |
Isis Pharmaceuticals, Inc. |
N-(aminoalkyl)- and/or N-(amidoalkyl)- dinitrogen heterocyclic compositions
|
|
FR2758328B1
(fr)
|
1997-01-15 |
1999-04-02 |
Pf Medicament |
Nouvelles amines aromatiques derivees d'amines cycliques utiles comme medicaments
|
|
FR2758327B1
(fr)
|
1997-01-15 |
1999-04-02 |
Pf Medicament |
Nouvelles arylpiperazines derivees de piperidine
|
|
AU742391B2
(en)
*
|
1997-08-20 |
2002-01-03 |
Regents Of The University Of California, The |
Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof
|
|
JPH11199573A
(ja)
|
1998-01-07 |
1999-07-27 |
Yamanouchi Pharmaceut Co Ltd |
５ｈｔ３受容体作動薬及び新規ベンゾチアゾール誘導体
|
|
TR200002182T2
(tr)
*
|
1998-01-27 |
2000-12-21 |
Aventis Pharmaceuticals Products Inc. |
İkame edilmiş aksozaherosayklil faktör xa inhibitörleri
|
|
EP0943683A1
(en)
*
|
1998-03-10 |
1999-09-22 |
Smithkline Beecham Plc |
Human vanilloid receptor homologue Vanilrep1
|
|
EP1087962A4
(en)
|
1998-06-19 |
2001-10-04 |
Lilly Co Eli |
PRODUCTION OF HETEROARYL COMPOUNDS
|
|
WO2000001688A1
(en)
|
1998-07-02 |
2000-01-13 |
Sankyo Company, Limited |
Five-membered heteroaryl compounds
|
|
ES2300151T3
(es)
*
|
1998-09-22 |
2008-06-01 |
Astellas Pharma Inc. |
Derivados de cianofenilo.
|
|
WO2000042852A1
(en)
|
1999-01-25 |
2000-07-27 |
Smithkline Beecham Corporation |
Compounds and methods
|
|
GB9907097D0
(en)
*
|
1999-03-26 |
1999-05-19 |
Novartis Ag |
Organic compounds
|
|
AP2005003199A0
(en)
|
1999-04-01 |
2005-03-31 |
Pfizer Prod Inc |
Aminopyrimidines as sorbitol dehydrogenase inhibitors
|
|
EP1183238A1
(en)
|
1999-05-17 |
2002-03-06 |
Eli Lilly And Company |
Metabotropic glutamate receptor antagonists
|
|
GB9912411D0
(en)
*
|
1999-05-28 |
1999-07-28 |
Pfizer Ltd |
Compounds useful in therapy
|
|
DE19934799B4
(de)
*
|
1999-07-28 |
2008-01-24 |
Az Electronic Materials (Germany) Gmbh |
Chiral-smektische Flüssigkristallmischung und ihre Verwendung in Aktivmatrix-Displays mit hohen Kontrastwerten
|
|
US7343017B2
(en)
*
|
1999-08-26 |
2008-03-11 |
American Technology Corporation |
System for playback of pre-encoded signals through a parametric loudspeaker system
|
|
WO2001017965A2
(en)
|
1999-09-07 |
2001-03-15 |
Syngenta Participations Ag |
Cyanopiperidines as pesticides
|
|
US6887870B1
(en)
|
1999-10-12 |
2005-05-03 |
Bristol-Myers Squibb Company |
Heterocyclic sodium/proton exchange inhibitors and method
|
|
JP2003521543A
(ja)
*
|
2000-02-07 |
2003-07-15 |
アボット ゲーエムベーハー ウント カンパニー カーゲー |
２−ベンゾチアゾリル尿素誘導体およびそのプロテインキナーゼ阻害剤としての使用
|
|
AU2001255600A1
(en)
|
2000-04-25 |
2001-11-07 |
Pharmacia Corporation |
Regioselective synthesis of 3,4-di(carbocyclyl or heterocyclyl)thiophenes
|
|
AU8181701A
(en)
*
|
2000-06-21 |
2002-01-02 |
Hoffmann La Roche |
Benzothiazole derivatives
|
|
AR028782A1
(es)
*
|
2000-07-05 |
2003-05-21 |
Taisho Pharmaceutical Co Ltd |
Derivados heterociclicos tetrahidropiridino o piperidino
|
|
WO2002006196A1
(en)
*
|
2000-07-13 |
2002-01-24 |
Merck Patent Gmbh |
Chiral compounds i
|
|
JP2004525071A
(ja)
*
|
2000-07-20 |
2004-08-19 |
ニューロジェン コーポレイション |
カプサイシン受容体リガンド
|
|
IL154927A0
(en)
*
|
2000-10-18 |
2003-10-31 |
Pfizer Prod Inc |
Combination of statins and sorbitol dehydrogenase inhibitors
|
|
BR0115783A
(pt)
*
|
2000-11-30 |
2003-09-16 |
Pfizer Prod Inc |
Combinação de agonistas de gaba e inibidores de sorbitol desidrogenase
|
|
AU2002222644A1
(en)
|
2000-12-15 |
2002-06-24 |
Japan Science And Technology Corporation |
Arylbis (perfluoroalkylsulfonyl) methane, metal salt of the same, and processes for producing these
|
|
US7193113B2
(en)
*
|
2000-12-15 |
2007-03-20 |
Japan Science And Technology Corporation |
Arylbis(perfluoroalkylsulfonyl) methane and metallic salt thereof, and methods for producing the same
|
|
US20030232996A1
(en)
|
2001-04-20 |
2003-12-18 |
Brown David L |
Regioselective synthesis of 3,4-di{(carboclyl or heterocyclyl)thiophenes
|
|
CA2446380A1
(en)
|
2001-05-08 |
2002-11-14 |
Yale University |
Proteomimetic compounds and methods
|
|
US20040038982A1
(en)
*
|
2001-07-13 |
2004-02-26 |
Bondinell William E. |
Compounds and methods
|
|
JP2003095951A
(ja)
|
2001-09-25 |
2003-04-03 |
Sumitomo Pharmaceut Co Ltd |
慢性関節リウマチ治療剤
|
|
WO2003029199A1
(en)
*
|
2001-09-28 |
2003-04-10 |
Takeda Chemical Industries, Ltd. |
Benzene derivatives, process for preparing the same and use thereof
|
|
CA2470612A1
(en)
|
2001-12-19 |
2003-07-03 |
Merck & Co., Inc. |
Heteroaryl substituted imidazole modulators of metabotropic glutamate receptor-5
|
|
US7390813B1
(en)
*
|
2001-12-21 |
2008-06-24 |
Xenon Pharmaceuticals Inc. |
Pyridylpiperazines and aminonicotinamides and their use as therapeutic agents
|
|
US20050119251A1
(en)
*
|
2001-12-21 |
2005-06-02 |
Jian-Min Fu |
Nicotinamide derivatives and their use as therapeutic agents
|
|
JP2003192673A
(ja)
|
2001-12-27 |
2003-07-09 |
Bayer Ag |
ピペラジンカルボキシアミド誘導体
|
|
WO2003066595A2
(en)
*
|
2002-02-01 |
2003-08-14 |
Euro-Celtique S.A. |
2 - piperazine - pyridines useful for treating pain
|
|
ES2316777T3
(es)
*
|
2002-02-15 |
2009-04-16 |
Glaxo Group Limited |
Moduladores de receptores vainilloides.
|
|
US6974818B2
(en)
*
|
2002-03-01 |
2005-12-13 |
Euro-Celtique S.A. |
1,2,5-thiadiazol-3-YL-piperazine therapeutic agents useful for treating pain
|
|
DE60326436D1
(en)
*
|
2002-03-13 |
2009-04-16 |
Janssen Pharmaceutica Nv |
Aminoderivate als histone-deacetylase-inhibitoren
|
|
GB0209715D0
(en)
*
|
2002-04-27 |
2002-06-05 |
Astrazeneca Ab |
Chemical compounds
|
|
CN1150176C
(zh)
*
|
2002-05-22 |
2004-05-19 |
上海医药工业研究院 |
芳烷酮哌嗪衍生物及其应用
|
|
WO2003099266A2
(en)
*
|
2002-05-23 |
2003-12-04 |
Abbott Laboratories |
Acetamides and benzamides that are useful in treating sexual dysfunction
|
|
DK1522314T3
(da)
*
|
2002-06-26 |
2014-05-26 |
Ono Pharmaceutical Co |
Midler for sygdomme forårsaget af vaskulær sammentrækning eller udvidelse
|
|
PT1556354E
(pt)
*
|
2002-06-28 |
2008-04-17 |
Euro Celtique Sa |
Derivados de piperazina úteis como agentes terapêuticos para o tratamento da dor
|
|
EP1388538B1
(en)
|
2002-07-09 |
2010-09-01 |
Merck Patent GmbH |
Polymerisation Initiator
|
|
US7262194B2
(en)
*
|
2002-07-26 |
2007-08-28 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
|
AU2003256922A1
(en)
|
2002-07-31 |
2004-02-16 |
Smithkline Beecham Corporation |
Substituted heterocyclic compounds as modulators of the ccr5 receptor
|
|
US7157462B2
(en)
*
|
2002-09-24 |
2007-01-02 |
Euro-Celtique S.A. |
Therapeutic agents useful for treating pain
|
|
AU2003271064B2
(en)
|
2002-09-27 |
2010-06-17 |
Dainippon Sumitomo Pharma Co., Ltd. |
Novel adenine compound and use thereof
|
|
EP1551811A1
(en)
*
|
2002-10-17 |
2005-07-13 |
Amgen Inc. |
Benzimidazole derivatives and their use as vanilloid receptor ligands
|
|
US7582635B2
(en)
|
2002-12-24 |
2009-09-01 |
Purdue Pharma, L.P. |
Therapeutic agents useful for treating pain
|
|
US7223788B2
(en)
|
2003-02-14 |
2007-05-29 |
Sanofi-Aventis Deutschland Gmbh |
Substituted N-aryl heterocycles, process for their preparation and their use as medicaments
|
|
DE10311065A1
(de)
*
|
2003-03-13 |
2004-09-23 |
Abbott Gmbh & Co. Kg |
Pyrimidin-2-on-Verbindungen und ihre therapeutische Verwendung
|
|
WO2004103954A1
(ja)
*
|
2003-05-20 |
2004-12-02 |
Ajinomoto Co., Inc. |
アミド誘導体
|
|
MY142655A
(en)
|
2003-06-12 |
2010-12-15 |
Euro Celtique Sa |
Therapeutic agents useful for treating pain
|
|
US7129235B2
(en)
*
|
2003-07-11 |
2006-10-31 |
Abbott Laboratories |
Amides useful for treating pain
|
|
US20050009841A1
(en)
*
|
2003-07-11 |
2005-01-13 |
Zheng Guo Zhu |
Novel amides useful for treating pain
|
|
EP1867644B1
(en)
|
2003-07-24 |
2009-05-20 |
Euro-Celtique S.A. |
Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain
|
|
AU2004259357B2
(en)
|
2003-07-24 |
2010-02-18 |
Euro-Celtique S.A. |
Piperidine compounds and pharmaceutical compositions containing them
|
|
SI1867644T1
(sl)
|
2003-07-24 |
2009-10-31 |
Euro Celtique Sa |
Heteroaril-tetrahidropiperidilne spojine, koristne za zdravljenje ali preprečevanje bolečine
|
|
MXPA06001202A
(es)
*
|
2003-07-29 |
2006-08-31 |
Xenon Pharmaceuticals Inc |
Derivados piridilo y su uso como agentes terapeuticos.
|
|
US7754711B2
(en)
*
|
2003-07-30 |
2010-07-13 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
CN1829701A
(zh)
*
|
2003-07-30 |
2006-09-06 |
泽农医药公司 |
哌嗪衍生物和它们作为治疗剂的用途
|
|
EP1648874B1
(en)
*
|
2003-07-30 |
2011-10-05 |
Xenon Pharmaceuticals Inc. |
Piperazine derivatives and their use as therapeutic agents
|
|
US7759348B2
(en)
*
|
2003-07-30 |
2010-07-20 |
Xenon Pharmaceuticals Inc. |
Pyridazine derivatives and their use as therapeutic agents
|
|
KR20060036106A
(ko)
*
|
2003-07-30 |
2006-04-27 |
제논 파마슈티칼스 인크. |
피리딜 유도체 및 그의 치료제로서의 용도
|
|
CN101712653A
(zh)
*
|
2003-07-30 |
2010-05-26 |
泽农医药公司 |
哒嗪衍生物和它们作为治疗剂的用途
|
|
JP4866610B2
(ja)
*
|
2003-08-18 |
2012-02-01 |
富士フイルムファインケミカルズ株式会社 |
ピリジルテトラヒドロピリジン類およびピリジルピペリジン類
|
|
WO2005037284A1
(en)
|
2003-10-15 |
2005-04-28 |
Pfizer Products Inc. |
Sorbitol dehydrogenase inhibitor and hypertensive agent combinations
|
|
US20050130974A1
(en)
*
|
2003-10-17 |
2005-06-16 |
Rigel Pharmaceuticals, Inc. |
Benzothiazole compositions and their use as ubiquitin ligase inhibitors
|
|
GB0325287D0
(en)
|
2003-10-29 |
2003-12-03 |
Merck Sharp & Dohme |
Therapeutic agents
|
|
MY145822A
(en)
*
|
2004-08-13 |
2012-04-30 |
Neurogen Corp |
Substituted biaryl piperazinyl-pyridine analogues
|
|
DE102004039789A1
(de)
*
|
2004-08-16 |
2006-03-02 |
Sanofi-Aventis Deutschland Gmbh |
Arylsubstituierte polycyclische Amine, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
EP1827438B2
(en)
*
|
2004-09-20 |
2014-12-10 |
Xenon Pharmaceuticals Inc. |
Piperazin derivatives for inhibiting human stearoyl-coa-desaturase
|
|
CA2580857A1
(en)
*
|
2004-09-20 |
2006-09-28 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
|
CA2580762A1
(en)
*
|
2004-09-20 |
2006-03-30 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as therapeutic agents
|
|
EP1807085B1
(en)
*
|
2004-09-20 |
2013-08-21 |
Xenon Pharmaceuticals Inc. |
Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
|
|
US20060116368A1
(en)
*
|
2004-11-29 |
2006-06-01 |
Calvo Raul R |
4-Piperidinecarboxamide modulators of vanilloid VR1 receptor
|
|
GT200600046A
(es)
*
|
2005-02-09 |
2006-09-25 |
|
Terapia de combinacion
|
|
ES2400287T3
(es)
*
|
2005-03-14 |
2013-04-08 |
High Point Pharmaceuticals, Llc |
Derivados de benzazol, composiciones y procedimientos de uso como inhibidores de beta-secretasa
|
|
DE102005014904A1
(de)
|
2005-03-26 |
2007-02-01 |
Abbott Gmbh & Co. Kg |
Substituierte Oxindol-Derivate, diese enthaltende Arzneimittel und deren Verwendung
|
|
FR2884516B1
(fr)
|
2005-04-15 |
2007-06-22 |
Cerep Sa |
Antagonistes npy, preparation et utilisations
|
|
US8193206B2
(en)
|
2005-06-14 |
2012-06-05 |
Taigen Biotechnology Co., Ltd. |
Pyrimidine compounds
|
|
JP4324221B2
(ja)
|
2005-08-26 |
2009-09-02 |
株式会社医薬分子設計研究所 |
Ｐｐａｒアゴニスト活性を有する誘導体
|
|
AU2006296004B2
(en)
|
2005-09-27 |
2011-11-17 |
Shionogi & Co., Ltd. |
Sulfonamide derivative having PGD2 receptor antagonistic activity
|
|
US20070155707A1
(en)
*
|
2005-12-29 |
2007-07-05 |
Kadmus Pharmaceuticals, Inc. |
Ionizable inhibitors of fatty acid amide hydrolase
|
|
ATE460404T1
(de)
|
2006-01-18 |
2010-03-15 |
Siena Biotech Spa |
Modulatoren von alpha7-nikotin-acetylcholin- rezeptoren und therapeutische anwendungen davon
|
|
EP2562168B1
(en)
*
|
2006-02-28 |
2014-04-16 |
Dart Neuroscience (Cayman) Ltd |
Therapeutic piperazines as pde4 inhibitors
|
|
WO2007103719A2
(en)
*
|
2006-03-03 |
2007-09-13 |
Incyte Corporation |
MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
|
TW200815426A
(en)
*
|
2006-06-28 |
2008-04-01 |
Astrazeneca Ab |
New pyridine analogues II 333
|
|
WO2008005368A2
(en)
*
|
2006-06-30 |
2008-01-10 |
Abbott Laboratories |
Piperazines as p2x7 antagonists
|
|
WO2008013622A2
(en)
|
2006-07-27 |
2008-01-31 |
E. I. Du Pont De Nemours And Company |
Fungicidal azocyclic amides
|
|
US20080182851A1
(en)
*
|
2006-11-20 |
2008-07-31 |
Glenmark Pharmaceuticals S.A. |
Acetylene derivatives as stearoyl coa desaturase inhibitors
|
|
DE102006060598A1
(de)
*
|
2006-12-21 |
2008-06-26 |
Merck Patent Gmbh |
Tetrahydrobenzoisoxazole
|
|
EP2139869A2
(en)
*
|
2007-04-13 |
2010-01-06 |
SuperGen, Inc. |
Axl kinase inhibitors useful for the treatment of cancer or hyperproliferative disorders
|
|
WO2008133973A1
(en)
*
|
2007-04-27 |
2008-11-06 |
Purdue Pharma L.P. |
Therapeutic agents useful for treating pain
|
|
DK2142529T3
(da)
*
|
2007-04-27 |
2014-02-10 |
Purdue Pharma Lp |
Trpv1-antagonister og anvendelser deraf
|
|
WO2008147864A2
(en)
|
2007-05-22 |
2008-12-04 |
Xenon Pharmaceuticals Inc. |
Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions
|
|
US8058299B2
(en)
*
|
2007-05-22 |
2011-11-15 |
Via Pharmaceuticals, Inc. |
Diacylglycerol acyltransferase inhibitors
|
|
AU2008287542C1
(en)
|
2007-06-01 |
2015-01-22 |
The Trustees Of Princeton University |
Treatment of viral infections by modulation of host cell metabolic pathways
|
|
EP2167074A2
(en)
|
2007-06-13 |
2010-03-31 |
NorthEastern University |
Antibiotic compounds
|
|
JP2010531360A
(ja)
|
2007-06-28 |
2010-09-24 |
インターベット インターナショナル ベー． フェー． |
Ｃｂ１拮抗剤としてのピペラジンの使用
|
|
KR20100045983A
(ko)
|
2007-06-29 |
2010-05-04 |
에모리 유니버시티 |
신경보호를 위한 ｎｍｄａ 수용체 길항물질
|
|
US7998982B2
(en)
*
|
2007-08-09 |
2011-08-16 |
Abbott Laboratories |
Amide derivatives as TRPV1 antagonists
|
|
US7994174B2
(en)
*
|
2007-09-19 |
2011-08-09 |
Vertex Pharmaceuticals Incorporated |
Pyridyl sulfonamides as modulators of ion channels
|
|
US8138168B1
(en)
|
2007-09-26 |
2012-03-20 |
Takeda Pharmaceutical Company Limited |
Renin inhibitors
|
|
ES2428326T3
(es)
|
2007-10-04 |
2013-11-07 |
Merck Sharp & Dohme Corp. |
Derivados de aril sulfona sustituida como bloqueadores de canales de calcio
|
|
WO2009076512A1
(en)
|
2007-12-11 |
2009-06-18 |
Epix Delaware, Inc. |
Carboxamidξ compounds and their use as chemokine receptor agonists
|
|
JP2009249346A
(ja)
|
2008-04-08 |
2009-10-29 |
Fujifilm Corp |
ピリジン骨格を有する血液脳関門透過性化合物
|
|
CN102105465B
(zh)
|
2008-07-21 |
2015-03-11 |
普渡制药公司 |
取代的喹喔啉型桥连哌啶化合物及其用途
|